El texto completo de este trabajo no está disponible en el Repositorio Académico UPC por restricciones de la casa editorial donde ha sido publicado.

In low- and middle-income countries (LMICs), 85% of cervical cancer diagnoses and 88% of cervical cancer deaths occur annually.1,2 The majority of presentations (with reports up to 75%)3 are locally advanced (International Federation of Gynecology and Obstetrics stages IB2 and IIBIVA) where combination external beam radiation therapy (EBRT) followed by brachytherapy is indicated for curative treatment.4 Despite large bodies of evidence that radiation therapy (RT) is effective for treating cancer, a shortage of economic investment limits its availability and contributes to global shortages.5,6 RT is generally described as a costeffective treatment, but only limited data exists about the institutional cost of combination RT in LMICs.7 Understanding treatment costs is critical for cancer capacity planning efforts, particularly in regions where radiation oncology is less understood or newly ...

Background: Continuing medical education in stereotactic technology are scarcely accessible in developing countries. We report the results of upscaling a longitudinal telehealth training course on stereotactic body radiation therapy (SBRT) and stereotactic radiosurgery (SRS), after successfully developing a pilot course in Latin America. Methods: Longitudinal training on SBRT and SRS was provided to radiation oncology practitioners in Peru and Colombia at no cost. The program included sixteen weekly 1-hour live conferencing sessions with interactive didactics and a cloud-based platform for case-based learning. Participant-reported confidence was measured in 16 SBRT/SRS practical domains, based on a 1-to-5 Likert scale. Pre- and post-curriculum exams were required for participation credit. Knowledge-baseline, pre- and post-curriculum surveys, overall and single professional-group confiden...

This research was funded by Consejo Nacional de Ciencia, Tecnologia e Innovacion Tecnologica de Peru (grant N~ 024-2019-Fondecyt-BM-INC.INV and CONCYTEC-FONDECYT-E038-01).